[ad_1]
“Today we talk about the fact that for all population groups, about 70 percent. population, the vaccine would be free, “said the prime minister.
The Prime Minister said that Lithuania, by making the decision to buy all existing vaccines, differentiates the potential risks, as do many European countries.
“Today, it is not absolutely clear who will make the manufacturers’ vaccine, if they all produce it, which one will be the most effective,” Skvernel said.
According to him, in terms of dose, around 70% could be vaccinated voluntarily. populations. According to S. Skvernelis, the prices of vaccines vary widely from 2.9 to 18 euros. However, according to the Prime Minister, no member of the Community can negotiate a price.
“If the seven companies produced these vaccines and we had to buy them all under the contract, there would be a surplus of vaccines, so yesterday it was decided to start negotiations with the Eastern Partnership countries and talk. <...> I hope we can offer a non-Russian vaccine if they are produced, “said S. Skvernelis.
The theoretical maximum amount that a vaccine deal could reach, according to the prime minister, is 125 million. euros.
“Even to the max, <...> this would mean an average charge of 40 euros per capita. We hope that this maximum number is not necessary, “said the Prime Minister.
The Prime Minister pointed out that the Member States will not carry out public procurement themselves, everything will be carried out through the European institutions.
“It’s a shame that even on issues so important and essential to our state, the dilettante approach scares me. I keep wondering what would happen if those people were in control of the state and had to make decisions. To put it mildly, it’s scary.” the prime minister responded to opposition criticism of the vaccine.
According to S. Skvernel, it is necessary to delve into existing information and not follow rumors or relate to elections.
“It is low and incorrect,” said the head of government.
Lithuania, along with other European Union countries, will participate in the procurement of the seven COVID-19 vaccines under development, which are being negotiated by the European Commission, the government decided on Wednesday. This was approved by the Cabinet of Ministers in accordance with an earlier decision of the Government’s National Security Commission.
The European Commission has signed an agreement with AstraZeneca, a British and Swedish pharmaceutical company, to buy COVID-19, but six potential manufacturers are in talks.
Prime Minister Saulius Skvernelis and Health Minister Aurelijus Veryga stated that if all vaccines are approved as effective and safe, Lithuania may have to pay more than 100 million for them. And deciding not to buy at least some of the vaccines would put the country at risk of not getting an effective vaccine at all.
[ad_2]
